🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Inflammation is reported as one of the most recent hypotheses to explain BP...
Status
Completed
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01604811
Open-label, 6 month-treatment with the IP in all subjects. - Sample size: A...
Status
Terminated
Location
GSK Investigational Site
Start Date
2012-06-29
Trial ID
NCT01673490
Treatments Being Tested
This study is an open-label, randomized, fasted, single dose, crossover stu...
Status
Completed
Location
Bestian Hospital
Start Date
2019-03-11
Trial ID
NCT03887858
Treatments Being Tested
It will be an open-label, randomized, laboratory-blind, crossover study wit...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-01-04
Trial ID
NCT01262989
Treatments Being Tested
This study is an open-label, randomized, fed, single dose, crossover study ...
Status
Completed
Location
Bestian Hospital
Start Date
2019-03-11
Trial ID
NCT03887871
Treatments Being Tested
To compare the relative bioavailability and pharmacokinetic characteristics...
Status
Completed
Location
Clinical trial center of Anam Hospital
Start Date
2012-01
Trial ID
NCT01829893
Treatments Being Tested
It will be an open-label, randomized, laboratory-blind, crossover study wit...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-12-08
Trial ID
NCT01330303
Treatments Being Tested
Prospective, longitudinal, single-dose, randomized, open-label, crossover 2...
Status
Completed
Location
Axis Clinicals Latina, S.A. de C.V.
Start Date
2026-02-12
Trial ID
NCT07698288
Treatments Being Tested
A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 U...
Status
Recruiting
Location
H PLUS YANGJI HOSPITAL, Seoul
Start Date
2026-02-26
Trial ID
NCT07444385
Treatments Being Tested
Prospective, longitudinal, single-dose, randomized, open-label, crossover 2...
Status
Completed
Location
Axis Clinicals Latina, S.A. de C.V.
Start Date
2026-01-12
Trial ID
NCT07698275
Treatments Being Tested